These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26384489)

  • 1. Association of Attorney Advertising and FDA Action with Prescription Claims: A Time Series Segmented Regression Analysis.
    Tippett EC; Chen BK
    Drug Saf; 2015 Dec; 38(12):1169-78. PubMed ID: 26384489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Advice from Lawyers: A Content Analysis of Advertising for Drug Injury Lawsuits.
    Tippett E
    Am J Law Med; 2015; 41(1):7-48. PubMed ID: 26237982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.
    Mintzes B; Morgan S; Wright JM
    PLoS One; 2009 May; 4(5):e5699. PubMed ID: 19479084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B
    Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Despite 2007 law requiring FDA hotline to be included in print drug ads, reporting of adverse events by consumers still low.
    Du D; Goldsmith J; Aikin KJ; Encinosa WE; Nardinelli C
    Health Aff (Millwood); 2012 May; 31(5):1022-9. PubMed ID: 22566442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The federal regulation of prescription drug advertising and promotion.
    Kessler DA; Pines WL
    JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Rollins BL
    Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Carpentier FR
    Int J Health Policy Manag; 2016 Feb; 5(4):283-5. PubMed ID: 27239874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
    Bradford WD; Kleit AN
    Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Attorney Advertising Influence Patient Perceptions of Pelvic Mesh?
    Tippett E; King J; Lucent V; Ephraim S; Murphy M; Taff E
    Urology; 2018 Jan; 111():65-71. PubMed ID: 29031838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.